VNRX Positive Sentiment
Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs
Friday, October 17, 2025 BiopharmaWatch Research 1 min read Key Takeaway: VolitionRx Limited has donated its Nu.Q® Vet Cancer Tests to the HOPE Animal-Assisted Crisis Response Dogs, enhancing support for therapy dogs that aid individuals in crisis. This initiative aligns with Volition's corporate social responsibility strategy and highlights their commitment to animal health. The donation was announced during the HOPE AACR Annual Conference in Virginia Beach.
Full Press Release Details
HENDERSON, Nev.,Oct. 17, 2025/PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), and its subsidiary, Volition Veterinary Diagnostics Development LLC, in line with their corporate social responsibility strategy announces participation at the HOPE Animal-Assisted Crisis Response Dogs (HOPE AACR) Annual Conference in Virginia Beach. Volition donated its Nu.Q® Vet Cancer Test to support dogs that provide emotional comfort and support to people affected by crises and disasters across the United States.
Dr. Michelle Silver, DVM, DACVIM – Oncology, commented: